Weight Loss Peptides: The Complete Miami Patient Guide

This is a complete patient-facing guide to weight loss peptides in Miami. Written by a physician-led concierge clinic, it covers the categories of peptides used for weight loss, what the clinical evidence actually shows, what physician supervision looks like in practice, and how the TrufaMED program structures care for patients pursuing medical weight loss.

If you are doing initial research on peptides for weight loss, this guide will save you hours of conflicting information. If you are ready to start a clinical protocol, the consultation booking is at the bottom.

Categories of weight loss peptides

The peptide category most relevant to weight loss is the GLP-1 receptor agonist family. These are technically peptides, prescribed as once-weekly subcutaneous injections, and produce the largest mean weight reduction of any FDA-approved class. The two principal GLP-1 medications are semaglutide (sold under brand names including Ozempic for diabetes and Wegovy for weight loss) and tirzepatide (Mounjaro for diabetes, Zepbound for weight loss). Tirzepatide also activates GIP receptors in addition to GLP-1, making it a dual agonist with the largest reported mean weight reduction in head-to-head trials.

A second category is growth hormone-releasing peptides: sermorelin (a GHRH analog) and tesamorelin (a GHRF analog). These are not first-line weight loss medications. Their role is in body composition support, particularly visceral fat reduction with tesamorelin and lean mass preservation with sermorelin. Both require baseline IGF-1 labs and physician monitoring.

A third category is adjunctive metabolic peptides (AOD-9604, MOTS-c, CJC-1295, ipamorelin). These have varying levels of clinical evidence — most have weak or preliminary support for weight loss as a primary indication. We use them selectively in protocols where a specific physiological target makes sense for the individual patient.

A fourth category, tissue regeneration peptides (GHK-Cu, BPC-157, TB-500), is sometimes confused with weight loss peptides in online marketing but is not a weight loss category. These are recovery and tissue repair peptides used in performance medicine protocols.

What the evidence actually supports for weight loss

The evidence hierarchy for weight loss peptides is clear. GLP-1 medications (semaglutide and tirzepatide) have the strongest evidence by a wide margin: large randomized controlled trials, FDA approval for chronic weight management, established safety profile, and mean weight reduction of 15 to 22 percent at one year. Tesamorelin has FDA approval for HIV-associated lipodystrophy with documented visceral adipose reduction; off-label use in metabolic syndrome is supported by smaller studies. Sermorelin has indirect support through its mechanism (raising endogenous IGF-1) for body composition outcomes in adults with documented deficiency.

For peptides like AOD-9604, MOTS-c, and CJC-1295, the human evidence for weight loss as a primary outcome is weak or absent. These peptides are widely sold online but should not be the basis of a serious weight loss protocol.

What physician supervision actually looks like

Physician supervision for peptide therapy is not a single video call followed by a vial in the mail. The TrufaMED program structures supervision around three components: baseline assessment, monthly physician review, and direct access during the protocol.

The baseline assessment includes a comprehensive consultation, comprehensive metabolic panel, lipid panel, HbA1c, fasting insulin, IGF-1 (if growth hormone peptides are being considered), thyroid panel, vitamin D, and a body composition scan. Without these labs, peptide therapy is guesswork.

Monthly review includes weight tracking, side-effect screening, dose titration if appropriate, and discussion of adherence and side effects. The physician adjusts the protocol based on response, not a fixed protocol on paper.

Direct access means you can message your physician through our concierge system between visits when something feels off. Most concerns are resolved with a dose adjustment or a brief in-clinic visit. This access is what separates a clinical protocol from a vial purchase.

How TrufaMED prescribes peptides

The TrufaMED weight loss program prescribes GLP-1 medications (tirzepatide or semaglutide) as the primary intervention for patients seeking medical weight loss. Selection between them depends on labs, history, cardiovascular risk, and tolerance.

The performance medicine program separately prescribes growth hormone-releasing peptides (sermorelin, tesamorelin) and tissue regeneration peptides (GHK-Cu) for patients pursuing body composition, recovery, or longevity goals. Some patients enroll in both programs.

We do not prescribe AOD-9604, MOTS-c, BPC-157, or other peptides whose evidence base does not support the indication. We do not source from unregulated international or "research only" vendors. All peptides are dispensed through licensed US 503A or 503B compounding pharmacies, with sourcing disclosed to the patient.

For full program details, see Weight Loss Program Miami (GLP-1 protocols) and Performance Medicine Miami (peptide therapy, GHK-Cu, sermorelin, tesamorelin).

What to ask before starting any peptide protocol in Miami

If you are evaluating a peptide provider in Miami, here are the questions that separate clinical practices from vial vendors:

1. Will a board-certified physician prescribe this protocol after reviewing my labs?
2. What labs will be drawn before starting and how often will they be repeated?
3. Where is the peptide compounded and is the pharmacy licensed in the United States?
4. How is the dose titrated if I have side effects?
5. How do I reach my prescribing physician between visits if something is wrong?
6. What is included in the price beyond the peptide itself?

If the answers are vague, the practice is operating closer to a vial vendor model than a clinical protocol. Look elsewhere.

Starting a consultation

To enroll in the TrufaMED weight loss program or performance medicine program, message us on WhatsApp at +1 (305) 842-9801. We respond during clinic hours and schedule your first physician consultation within 24 to 48 hours.

The consultation reviews your goals, history, prior weight loss attempts, current medications, and any contraindications. If you are appropriate for the program, we order labs the same day; your protocol is designed once labs return.

Frequently asked questions

What are the most prescribed weight loss peptides in 2026?

GLP-1 receptor agonists tirzepatide and semaglutide are the most prescribed weight loss peptides globally. Both are FDA-approved for chronic weight management and produce the largest mean weight reduction of any peptide class in clinical trials.

Are weight loss peptides FDA-approved?

Some are, some are not. Tirzepatide (Zepbound for weight loss, Mounjaro for diabetes) and semaglutide (Wegovy for weight loss, Ozempic for diabetes) are FDA-approved. Tesamorelin is FDA-approved for HIV-associated lipodystrophy. Sermorelin, GHK-Cu, BPC-157, AOD-9604, MOTS-c, and others are not FDA-approved for weight loss; they are dispensed through licensed compounding pharmacies under physician prescription.

How long does it take for weight loss peptides to work?

GLP-1 medications typically produce noticeable appetite reduction in the first 1 to 2 weeks of treatment. Measurable weight loss begins in weeks 4 to 8 and continues over 6 to 12 months as dose is titrated up. Sermorelin and tesamorelin effects on body composition are more gradual, with measurable changes in 3 to 6 months.

Do weight loss peptides have side effects?

Yes. GLP-1 medications commonly cause nausea (especially during dose-up), reduced appetite, constipation, and occasional fatigue. Less common but significant risks include pancreatitis and gallbladder disease. Sermorelin and tesamorelin can cause injection-site reactions, occasional fluid retention, and require IGF-1 monitoring to avoid supraphysiological levels. The TrufaMED program titrates dose and monitors response to minimize side effects.

What labs are required before starting peptide therapy?

For GLP-1 weight loss therapy: comprehensive metabolic panel, lipid panel, HbA1c, fasting insulin, thyroid panel, lipase, amylase, and a body composition scan. For growth hormone-releasing peptides: add IGF-1, free testosterone, and pituitary function labs. The TrufaMED program includes all baseline and quarterly labs in the concierge membership.

Can I combine weight loss peptides with growth hormone-releasing peptides?

Yes, in selected protocols. Some patients enroll in both the TrufaMED weight loss program (tirzepatide or semaglutide) and the performance medicine program (sermorelin, tesamorelin, GHK-Cu) when their goals span weight loss, body composition, and longevity. Your physician designs an integrated protocol that accounts for both.

How much do weight loss peptides cost in Miami?

Pricing depends on peptide selection, dose, frequency, and concierge tier. The TrufaMED program is billed monthly as part of the concierge membership and includes peptide, physician visits, labs, and monitoring. Pricing is shared during your consultation. We do not publish a flat per-vial number because every protocol is individualized.

Are peptides legal in the United States?

FDA-approved peptide medications (tirzepatide, semaglutide, tesamorelin, others) are fully legal when prescribed by a licensed physician. Other peptides may be dispensed through licensed US 503A or 503B compounding pharmacies under physician prescription for specific patients. The "research use only" labeling used by online vendors is a regulatory loophole, not a legitimate medical pathway.

Are peptides covered by insurance?

Coverage varies. Tirzepatide and semaglutide may be covered for the diabetes indication for patients with type 2 diabetes; coverage for the weight loss indication is more variable and depends on plan. Other peptides (sermorelin, tesamorelin off-label, GHK-Cu) are typically paid out of pocket. HSA and FSA funds can usually be applied to physician-prescribed medications.

Can I get peptides without seeing a physician?

You can purchase peptides from online vendors operating under the "research use only" loophole, but this is not appropriate medical practice. Without baseline labs, dose monitoring, and physician supervision, the risks include incorrect dose, drug interactions, missed contraindications, and unmonitored side effects. The TrufaMED program operates as a physician-supervised clinical protocol, not a vial purchase.

What is the difference between the weight loss program and the performance medicine program?

The weight loss program focuses on FDA-approved GLP-1 medications (tirzepatide, semaglutide) for patients with weight loss as the primary goal. The performance medicine program focuses on injectable peptides (GHK-Cu, sermorelin, tesamorelin) for patients with longevity, recovery, body composition, or performance goals. Some patients enroll in both. Both are concierge-tier exclusive.

How do I book a consultation for the weight loss peptide program in Miami?

Message us on WhatsApp at +1 (305) 842-9801. We schedule a consultation with a board-certified physician within 24 to 48 hours, in-clinic at our Surfside location or via telehealth. Labs are ordered the same day if you are appropriate for the program.